跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZIEXTENZO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZIEXTENZO
Authorized
STANDARD
ZIEXTENZO
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8c494249acbbca60
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
8c494249acbbca60
Drug Approval Canada Name
ZIEXTENZO
Product Name
ZIEXTENZO
Status
Marketed
Status Date
2020-05-15
Original Market Date
2020-05-15
Din
02497395
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
20:16.00
Atc Original
L03AA13 PEGFILGRASTIM
Atc Name
l 03 aa 13
Aig Number
0149962001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
PEGFILGRASTIM
6 MG / 0.6 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8c494249acbbca60
Type
Standard
Back to Health Canada Approvals